Onderneming ACADIA Pharmaceuticals Inc.
Aandelen
ACAD
US0042251084
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
18,49 USD | +1,59% | +0,27% | -41,04% |
15:16 | Insider van Acadia Pharmaceuticals verkocht aandelen ter waarde van $317.081, volgens een recent SEC-document | MT |
25/03 | ACADIA PHARMACEUTICALS INC. : JPMorgan Chase nog altijd een koopadvies | ZM |
Vakgebied
Aantal werknemers: 598
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Innovative Medicines
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 517 | 100,0 % | 726 | 100,0 % | +40,45% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stephen Davis
CEO | Chief Executive Officer | 63 | 15-07-14 |
Mark Schneyer
DFI | Director of Finance/CFO | 50 | 28-05-20 |
Sanjeev Pathak
CTO | Chief Tech/Sci/R&D Officer | - | 01-03-21 |
Chief Tech/Sci/R&D Officer | 61 | 09-01-23 | |
Brendan Teehan
COO | Chief Operating Officer | 56 | 01-07-18 |
Ponni Subbiah
CTO | Chief Tech/Sci/R&D Officer | - | 01-10-19 |
Benir Ruano
CTO | Chief Tech/Sci/R&D Officer | - | 01-11-22 |
- | - | ||
Holly Valdiviez
SAM | Sales & Marketing | - | 01-04-22 |
Rob Ackles
HRO | Human Resources Officer | - | 01-01-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Julian Baker
BRD | Director/Board Member | 57 | 11-12-15 |
Edmund Harrigan
BRD | Director/Board Member | 71 | 25-11-15 |
Stephen Davis
CEO | Chief Executive Officer | 63 | 15-07-14 |
Don Soland
BRD | Director/Board Member | 65 | 20-03-15 |
Laura Brege
BRD | Director/Board Member | 66 | 01-05-08 |
Stephen Biggar
CHM | Chairman | 53 | 22-01-13 |
James Daly
BRD | Director/Board Member | 63 | 11-01-16 |
Director/Board Member | 66 | 29-09-20 | |
Adora Ndu
BRD | Director/Board Member | 43 | 10-10-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 164 771 521 | 163 914 354 ( 99,48 %) | 0 | 99,48 % |
Bedrijfsgegevens
ACADIA Pharmaceuticals, Inc.
12830 El Camino Real Suite 400
92130-3331, San Diego
+(858) 558-2871
http://www.acadia.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-41,04% | 3 mld. | |
+9,54% | 45,97 mld. | |
+52,73% | 43,93 mld. | |
+7,19% | 42,34 mld. | |
-8,78% | 28,27 mld. | |
+18,13% | 27,18 mld. | |
-21,39% | 19,44 mld. | |
+14,70% | 13,83 mld. | |
+32,16% | 12,4 mld. | |
+5,39% | 11,45 mld. |
- Beurs
- Aandelen
- Aandeel ACADIA Pharmaceuticals Inc. - Nasdaq
- Onderneming ACADIA Pharmaceuticals Inc.